Spaulding Clinical Research, LLC Expands Clinical Pharmacology Capabilities

WEST BEND, Wis. - July 1, 2015 - PRLog -- Spaulding Clinical Research, LLC (SCR), a leading global biopharmaceutical services provider, today announced that the Company had completed an expansion of their Clinical Pharmacology Unit located in West Bend, WI in order to meet growing client demand for expertise-based studies in the early phases of clinical development.

“As biopharmaceutical companies have been conducting more Phase I and Proof-of-Concept studies with increasing complexity, SCR has been well positioned to meet their needs. In this regard, we are a top provider of expertise-based Phase I services and have more than 200 beds, which is among the largest capacities for a single CRO research unit in the world,” said Cassandra Erato, Chief Operating Officer. “With our expansion complete, we are uniquely positioned to provide our customers with a level of flexibility that most units cannot.”

SCR’s Clinical Pharmacology Research Unit has been expanding capabilities and capacity for client programs since 2007 when the unit opened. With its most recent expansion, the unit now has 200 beds, representing the largest such facility in the region. The unit is comprised of a 12-bed FIH/ICU Unit and houses 96-beds of telemetry.

About Spaulding Clinical

Spaulding Clinical Research, LLC is a global CRO providing Phase I - IV drug development services to the biopharmaceutical industry. Spaulding Clinical Research operates a 200-bed Clinical Pharmacology Unit, a Core ECG Laboratory and provides full Biometrics/Scientific Affairs services.